156 related articles for article (PubMed ID: 15788112)
1. Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson's disease.
Perlemoine C; Macia F; Tison F; Coman I; Guehl D; Burbaud P; Cuny E; Baillet L; Gin H; Rigalleau V
Br J Nutr; 2005 Feb; 93(2):191-8. PubMed ID: 15788112
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight.
Macia F; Perlemoine C; Coman I; Guehl D; Burbaud P; Cuny E; Gin H; Rigalleau V; Tison F
Mov Disord; 2004 Feb; 19(2):206-12. PubMed ID: 14978678
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.
Montaurier C; Morio B; Bannier S; Derost P; Arnaud P; Brandolini-Bunlon M; Giraudet C; Boirie Y; Durif F
Brain; 2007 Jul; 130(Pt 7):1808-18. PubMed ID: 17535833
[TBL] [Abstract][Full Text] [Related]
4. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
5. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
[TBL] [Abstract][Full Text] [Related]
6. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
[TBL] [Abstract][Full Text] [Related]
7. Free-living energy expenditure reduced after deep brain stimulation surgery for Parkinson's disease.
Jorgensen HU; Werdelin L; Lokkegaard A; Westerterp KR; Simonsen L
Clin Physiol Funct Imaging; 2012 May; 32(3):214-20. PubMed ID: 22487156
[TBL] [Abstract][Full Text] [Related]
8. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
9. Subthalamic deep brain stimulation improves auditory sensory gating deficit in Parkinson's disease.
Gulberti A; Hamel W; Buhmann C; Boelmans K; Zittel S; Gerloff C; Westphal M; Engel AK; Schneider TR; Moll CK
Clin Neurophysiol; 2015 Mar; 126(3):565-74. PubMed ID: 25085452
[TBL] [Abstract][Full Text] [Related]
10. Effects of subthalamic nucleus deep brain stimulation and L-DOPA on blinking in Parkinson's disease.
Bologna M; Fasano A; Modugno N; Fabbrini G; Berardelli A
Exp Neurol; 2012 May; 235(1):265-72. PubMed ID: 22366535
[TBL] [Abstract][Full Text] [Related]
11. Implications of secondary unresponsiveness to dopaminergic drugs with preserved response to subthalamic nucleus stimulation in Parkinson's disease.
Lenka A; Jhunjhunwala KR; Stezin A; Manjunath M; Srinivas D; Yadav R; Pal PK
Neurol India; 2018; 66(Supplement):S135-S137. PubMed ID: 29503336
[TBL] [Abstract][Full Text] [Related]
12. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
[TBL] [Abstract][Full Text] [Related]
13. Weight gain after STN-DBS: The role of reward sensitivity and impulsivity.
Aiello M; Eleopra R; Foroni F; Rinaldo S; Rumiati RI
Cortex; 2017 Jul; 92():150-161. PubMed ID: 28494345
[TBL] [Abstract][Full Text] [Related]
14. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
15. Apraxia of eyelid opening after subthalamic deep brain stimulation may be caused by reduction of levodopa.
Umemura A; Toyoda T; Yamamoto K; Oka Y; Ishii F; Yamada K
Parkinsonism Relat Disord; 2008 Dec; 14(8):655-7. PubMed ID: 18316231
[TBL] [Abstract][Full Text] [Related]
16. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
[TBL] [Abstract][Full Text] [Related]
17. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
[TBL] [Abstract][Full Text] [Related]
18. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
19. Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease.
Sauleau P; Leray E; Rouaud T; Drapier S; Drapier D; Blanchard S; Drillet G; Péron J; Vérin M
Mov Disord; 2009 Oct; 24(14):2149-55. PubMed ID: 19735089
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of l-dopa and DBS-STN on saccadic eye movements in advanced Parkinson's disease.
Dec-Ćwiek M; Tutaj M; Gracies JM; Volkmann J; Rudzińska M; Słowik A; Szczudlik A
Neurol Neurochir Pol; 2017; 51(5):354-360. PubMed ID: 28669542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
